<DOC>
	<DOC>NCT02596997</DOC>
	<brief_summary>Provide patients with serious AdV infection or disease access to treatment with BCV.</brief_summary>
	<brief_title>Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease</brief_title>
	<detailed_description />
	<mesh_term>Adenoviridae Infections</mesh_term>
	<criteria>Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids Able to swallow medication, either tablet or liquid Previous dosing with Brincidofovir If female, not pregnant or trying to become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Adenovirus Brincidofovir</keyword>
</DOC>